Ingevity Corp buy BMO Capital Markets
Start price
10.12.25
/
50%
€46.50
Target price
10.12.26
€60.10
Performance (%)
26.24%
Price
08:46
?
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 26.24%. This prediction currently runs until 10.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | 0.814% | 0.814% |
| iShares Core DAX® | -0.437% | -5.315% |
| iShares Nasdaq 100 | -0.194% | 3.078% |
| iShares Nikkei 225® | -0.951% | -5.884% |
| iShares S&P 500 | -0.420% | 0.922% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat

